ArticleCancer medicine2025

Efficacy and Safety of a 3-Weekly TS-1 Adjuvant Regimen in Advanced Gastric Cancer: A Pilot Study.

Jihong Bae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.